Report Overview
The Global Insulin Pump Market Size is expected to be worth around US$ 10.6 Billion by 2034, from US$ 4.8 Billion in 2024, growing at a CAGR of 8.2% during the forecast period from 2025 to 2034. North America held a dominant market position, capturing more than a 47.15% share and holds US$ 2.2 Billion market value for the year.
Insulin Pump Market, Global Analysis, 2020-2024 (US$ Billion)
| Region | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| North America | 1.5 | 1.9 | 2.0 | 2.1 | 2.3 |
| Europe | 0.7 | 0.9 | 0.9 | 1.0 | 1.0 |
| Asia Pacific | 0.6 | 0.8 | 0.9 | 0.9 | 1.0 |
Key Regions and Countries
- North America
- US
- Canada
- Europe
- Germany
- France
- The UK
- Spain
- Italy
- Russia
- Netherland
- Rest of Europe
- Asia Pacific
- China
- Japan
- South Korea
- India
- New Zealand
- Singapore
- Thailand
- Vietnam
- Rest of APAC
- Latin America
- Brazil
- Mexico
- Rest of Latin America
- Middle East & Africa
- South Africa
- Saudi Arabia
- UAE
- Rest of MEA
Key Players Analysis
The global insulin pump market is highly competitive, with several key players driving innovation and market growth. Leading companies include Medtronic plc, Tandem Diabetes Care, Inc., Ypsomed AG, Insulet Corporation, and others, each offering advanced insulin pump technologies. The insulin pump market is experiencing growth driven by advancements in product development, new product launches, and regulatory approvals.
Innovations in pump technology and the introduction of more user-friendly models are expanding treatment options for diabetes patients. Additionally, regulatory approvals for new devices are enhancing market accessibility, contributing to increased adoption and market expansion.
- In February 2023, Roche Diabetes Care Inc. announced that its Accu-Chek Solo micropump system received 510(k) premarket approval. This system features interoperable technology, enhancing its integration with other diabetes management tools.
Industry leader Medtronic holds a dominant position in this market, driven by its extensive portfolio of insulin pumps and consumables designed for effective diabetes management. Medtronic’s leadership is bolstered by its continuous innovation and the frequent approval of new products by regulatory authorities, which support the company’s sustained growth and market presence.
- In September 2020, Medtronic announced the U.S. FDA’s approval of its MiniMed 770G hybrid closed-loop system. This system accesses and shares real-time Continuous Glucose Monitoring (CGM) and pump data and offers its benefits to younger children living with type 1 diabetes.
Hoffmann-La Roche AG is a global healthcare company headquartered in Basel, Switzerland, specializing in pharmaceuticals and diagnostics. It is known for its innovations in oncology, immunology, infectious diseases, and personalized medicine. Medtronic plc is a global leader in medical technology, headquartered in Dublin, Ireland. The company develops and manufactures a wide range of medical devices and therapies, including insulin pumps for diabetes management.
Top Key Players in the Insulin Pump Market
- Hoffmann-La Roche AG
- Medtronic plc
- Terumo Corporation
- Insulet Corporation
- Tandem Diabetes Care, Inc.
- Ypsomed AG
- ViCentra B.V.
- Microtec Medical Ltd
- Debiotech SA
- EOFLOW CO., LTD.
Recent Developments
- In May 2021, F. Hoffmann-La Roche Ltd. introduced the mySugr Pump Control feature within its mySugr app. This feature enables patients to manage their insulin pumps directly through their smartphones, allowing them to import data and monitor its status with ease.
- In June 2020, Tandem Diabetes Care, Inc. acquired Sugarmate, Inc., a move aimed at enhancing its technological offerings and broadening its product portfolio. The acquisition focused on developing the Sugarmate app, which provides innovative ways for individuals with diabetes to visualize and manage their therapy data. This strategic initiative not only expanded Tandem Diabetes Care’s product range but also integrated advanced digital solutions into its insulin pump systems. Such strategic actions reflect a broader trend in the market where companies seek to enhance their competitive edge through technological advancements and comprehensive product ecosystems.